{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:40:40Z","timestamp":1791247240123,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007301","name":"Kunming University of Science and Technology","doi-asserted-by":"publisher","award":["KH2022031Y"],"award-info":[{"award-number":["KH2022031Y"]}],"id":[{"id":"10.13039\/501100007301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","award":["202002AA100006"],"award-info":[{"award-number":["202002AA100006"]}],"id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","award":["202502AA310012"],"award-info":[{"award-number":["202502AA310012"]}],"id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202505AF350085"],"award-info":[{"award-number":["202505AF350085"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202401AY07001127"],"award-info":[{"award-number":["202401AY07001127"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2015DG034"],"award-info":[{"award-number":["2015DG034"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114893","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:24:13Z","timestamp":1774970653000},"page":"114893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Biomaterials-guided nanomedicine for familial adenomatous polyposis: lipid nanopartiscle RNA therapeutics with translational relevance"],"prefix":"10.1016","volume":"394","author":[{"given":"Wenjun","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianshuo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114893_bb0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-4-22","article-title":"Familial adenomatous polyposis","volume":"4","author":"Half","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jconrel.2026.114893_bb0010","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.5858\/arpa.2018-0570-RA","article-title":"Familial adenomatous polyposis syndrome: an update and review of extraintestinal manifestations","volume":"143","author":"Dinarvand","year":"2019","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.jconrel.2026.114893_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1023286520725","article-title":"Attenuated familial adenomatous polyposis (AFAP). A review of the literature","volume":"2","author":"Knudsen","year":"2003","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.jconrel.2026.114893_bb0020","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2007.136127","article-title":"Guidelines for the clinical management of familial adenomatous polyposis (FAP)","volume":"57","author":"Vasen","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2026.114893_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10689-025-00462-y","article-title":"Guidelines for familial adenomatous polyposis (FAP): challenges in defining clinical management for a rare disease","volume":"24","author":"Zare","year":"2025","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.jconrel.2026.114893_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cells12182256","article-title":"When you come to a fork in the road, take it: Wnt signaling activates multiple pathways through the APC\/Axin\/GSK-3 complex","volume":"12","author":"Li","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.114893_bb0035","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08022","article-title":"A novel GSK3-regulated APC:Axin interaction regulates Wnt signaling by driving a catalytic cycle of efficient \u03b2catenin destruction","volume":"4","author":"Pronobis","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2026.114893_bb0040","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1158\/0008-5472.CAN-07-5558","article-title":"C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine","volume":"68","author":"Wilkins","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114893_bb0045","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway","volume":"281","author":"He","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114893_bb0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/gut.48.4.515","article-title":"Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families","volume":"48","author":"Friedl","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2026.114893_bb0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jmg.36.1.14","article-title":"Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition","volume":"36","author":"Wallis","year":"1999","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jconrel.2026.114893_bb0060","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","article-title":"Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC","volume":"275","author":"Morin","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114893_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ymeth.2017.10.008","article-title":"Design, assembly, production, and transfection of synthetic modified mRNA","volume":"133","author":"Oh","year":"2018","journal-title":"Methods"},{"key":"10.1016\/j.jconrel.2026.114893_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3692937","article-title":"Generation of Otic lineages from integration-free human-induced pluripotent stem cells reprogrammed by mRNAs","volume":"2020","author":"Boddy","year":"2020","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.jconrel.2026.114893_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-57920-5","article-title":"Programmable mRNA therapeutics for controlled epigenomic modulation of single and multiplexed gene expression in diverse diseases","volume":"16","author":"O\u2019donnell","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114893_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-51301-0","article-title":"N1-methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation","volume":"15","author":"Monroe","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114893_bb0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","article-title":"N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice","volume":"217","author":"Andries","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114893_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020484","article-title":"Advances in oral drug delivery systems: challenges and opportunities","volume":"15","author":"Lou","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114893_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102210","article-title":"Advancements in rectal drug delivery systems: clinical trials, and patents perspective","volume":"14","author":"Rathi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114893_bb0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114893_bb0105","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1021\/acsnano.3c04507","article-title":"Fluorinated lipid nanoparticles for enhancing mRNA delivery efficiency","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114893_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.18609\/nai.2024.015","article-title":"Challenges and advances of the stability of mRNA delivery therapeutics","volume":"1","author":"Zhai","year":"2024","journal-title":"Nucl. Acid Insights"},{"key":"10.1016\/j.jconrel.2026.114893_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/biom14081036","article-title":"Enhancing vaccine efficacy and stability: a review of the utilization of nanoparticles in mRNA vaccines","volume":"14","author":"Parvin","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2026.114893_bb0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","article-title":"Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size","volume":"39","author":"Di","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114893_bb0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114893_bb0130","first-page":"959","article-title":"Progresses in diagnosis and treatment of familial adenomatous polyposis","volume":"61","author":"Feng","year":"2022","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.jconrel.2026.114893_bb0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s12276-020-0380-6","article-title":"Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond \u03b2-catenin and the destruction complex","volume":"52","author":"Jung","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.114893_bb0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114893_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","article-title":"Targeting the Wnt\/beta-catenin pathway in cancer: update on effectors and inhibitors","volume":"62","author":"Krishnamurthy","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2026.114893_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225525","article-title":"The regulation of bone metabolism and disorders by Wnt signaling","volume":"20","author":"Maeda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114893_bb0155","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1186\/s12967-025-07333-1","article-title":"Targeted protein degradation of Wnt\/\u03b2-catenin signaling pathway: an effective strategy for cancer therapy","volume":"23","author":"Mao","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114893_bb0160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/0192623315621192","article-title":"Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index < 1","volume":"44","author":"Zhong","year":"2016","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2026.114893_bb0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12985-025-02645-6","article-title":"Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications","volume":"22","author":"Leong","year":"2025","journal-title":"Virol. J."},{"key":"10.1016\/j.jconrel.2026.114893_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2026.114893_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14111092","article-title":"Advances in mRNA LNP-based cancer vaccines: mechanisms, formulation aspects, challenges, and future directions","volume":"14","author":"Ramadan","year":"2024","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jconrel.2026.114893_bb0180","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1021\/jacs.4c18308","article-title":"Lipid-siRNA organization modulates the intracellular dynamics of lipid nanoparticles","volume":"147","author":"Mo","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114893_bb0185","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.1039\/D5TB01556A","article-title":"Lipid nanoparticle-mediated targeted mRNA delivery and its application in cancer therapy","volume":"13","author":"Sui","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2026.114893_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"MRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114893_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112357","article-title":"Stability study of mRNA-lipid nanoparticles exposed to various conditions based on the evaluation between physicochemical properties and their relation with protein expression ability","volume":"14","author":"Kamiya","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114893_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114893_bb0205","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2342592","article-title":"Long-term stability and immunogenicity of lipid nanoparticle COVID-19 mRNA vaccine is affected by particle size","volume":"20","author":"Shi","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"issue":"2025","key":"10.1016\/j.jconrel.2026.114893_bb0210","article-title":"Nonviral targeted mRNA delivery: principles, progresses, and challenges","volume":"6","author":"He","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2026.114893_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1143157","article-title":"Off-target effects in CRISPR\/Cas9 gene editing","volume":"11","author":"Guo","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114893_bb0220","article-title":"Applications of CRISPR-Cas9 as an advanced genome editing system in life sciences","volume":"10","author":"Tavakoli","year":"2021","journal-title":"BioTech (Basel)"},{"key":"10.1016\/j.jconrel.2026.114893_bb0225","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1128\/MCB.01034-07","article-title":"Wnt\/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells","volume":"27","author":"Fevr","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2026.114893_bb0230","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008052","article-title":"Wnt signaling in cancer","volume":"4","author":"Polakis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jconrel.2026.114893_bb0235","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007880","article-title":"Frizzled and LRP5\/6 receptors for Wnt\/\u03b2-catenin signaling","volume":"4","author":"Macdonald","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jconrel.2026.114893_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16152686","article-title":"Unraveling cancer\u2019s Wnt signaling: dynamic control through protein kinase regulation","volume":"16","author":"T\u00fcmen","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.114893_bb0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2003.09.050","article-title":"Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME)","volume":"277","author":"Tanaka","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114893_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2026.114893_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2022.100450","article-title":"Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics","volume":"44","author":"Mukai","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2026.114893_bb0260","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114893_bb0265","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114893_bb0270","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1097\/CM9.0000000000003703","article-title":"Advances in nanocarrier-mediated cancer therapy: progress in immunotherapy, chemotherapy, and radiotherapy","volume":"138","author":"Peng","year":"2025","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jconrel.2026.114893_bb0275","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2165\/00003495-200161080-00003","article-title":"Intraperitoneal drug delivery of antineoplastics","volume":"61","author":"Markman","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2026.114893_bb0280","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40265-025-02195-9","article-title":"A clinical pharmacological perspective on intraperitoneal chemotherapy","volume":"85","author":"Rietveld","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2026.114893_bb0285","first-page":"646","article-title":"Intraperitoneal chemotherapy for colorectal cancer peritoneal metastasis","volume":"27","author":"Ye","year":"2024","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"10.1016\/j.jconrel.2026.114893_bb0290","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s11095-025-03917-0","article-title":"Physiological considerations and delivery strategies for targeting tumors through intraperitoneal delivery","volume":"42","author":"Jony","year":"2025","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114893_bb0295","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/112067210701700606","article-title":"Behaviour of the phakic iris-claw intraocular lens (Artisan \/Verisyse) during accommodation: an optical coherence biometry study","volume":"17","author":"Sekundo","year":"2007","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2026.114893_bb0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.jconrel.2026.114893_bb0305","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M18-2937","article-title":"Use of peripherally inserted central catheters in patients with advanced chronic kidney disease: a prospective cohort study","volume":"171","author":"Paje","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jconrel.2026.114893_bb0310","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2147\/AMEP.S94862","article-title":"Addressing the need and void of leadership and management development among medical students in the UK","volume":"6","author":"Sherwani","year":"2015","journal-title":"Adv. Med. Educ. Pract."},{"key":"10.1016\/j.jconrel.2026.114893_bb0315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.soin.2017.12.005","article-title":"Place and role of the body in christianity","volume":"63","author":"Verspieren","year":"2018","journal-title":"Soins"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:56:00Z","timestamp":1779756960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926002956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":63,"alternative-id":["S0168365926002956"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114893","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomaterials-guided nanomedicine for familial adenomatous polyposis: lipid nanopartiscle RNA therapeutics with translational relevance","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114893"}}